Fmoc-Orn(Dde)-OH is an Fmoc-protected ornithine derivative bearing an N-(Dde) (1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl) protecting group on the side-chain amino functionality, classifying it as a protected, non-free amino acid suitable for peptide chemistry. The molecule contains a carboxylic acid and an Fmoc-protected alpha-amino group framework, with the protected side-chain amine incorporated as a masked primary amine that can be deprotected under conditions compatible with Dde removal while maintaining the Fmoc strategy for orthogonal control. In synthesis and chemical biology workflows, this orthogonally protected amino acid is employed as a building block for stepwise peptide assembly where selective unveiling of the side-chain amine supports controlled conjugation, branching, or preparation of more complex amino acid and peptide derivatives.
CAT No: CP08718
CAS No:269062-80-8
Synonyms/Alias:N-α-Fmoc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-ornithine;Fmoc-Orn(Dde)-OH;269062-80-8;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)amino)pentanoicacid;L-Ornithine,N5-[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-;AmbotzFAA1502;SCHEMBL119272;09766_FLUKA;CTK8C5141;MolPort-003-925-671;C30H34N2O6;Nalpha-Fmoc-Ndelta-Dde-L-ornithine;ANW-74340;CF-837;AKOS015901450;ZINC100007889;RTR-012119;VA50399;AJ-67849;AK-61253;AM808150;AN-29256;SC-10400;FT-0644179;Z1935;I14-15345
Fmoc-Orn(Dde)-OH is a protected ornithine derivative bearing an Fmoc group on the α-amino function and a Dde protecting group on the side-chain primary amine, with the stereogenic α-carbon retained in the ornithine configuration. The molecule therefore contains an Fmoc carbamate chromophore for base-orthogonal peptide assembly, alongside a masked ε-amino functionality that can be selectively unmasked without disturbing the Fmoc handle. The carboxylic acid enables standard amino acid activation and peptide coupling, while the orthogonally protected side chain supports controlled branching, cyclization, or conjugation chemistries in downstream synthesis. The presence of two protecting groups with distinct deprotection triggers makes Fmoc-Orn(Dde)-OH a practical chiral amino acid intermediate for constructing polyamine-rich sequences and functionalized peptidomimetics.
1. Peptide Synthesis
Fmoc-Orn(Dde)-OH is used in solid-phase peptide synthesis where the Fmoc-protected α-amino group participates in stepwise chain elongation while the Dde-protected side-chain amine remains masked during the coupling cycles. The carboxylic acid functionality supports peptide coupling chemistry to generate amide bonds, and the orthogonal protection strategy enables selective side-chain deprotection for subsequent branching or post-synthetic modifications. The ornithine side chain provides a three-carbon spacer terminating in a primary amine after Dde removal, which can be incorporated into peptide scaffolds that require additional nucleophilic handles. The resulting peptide products can be further functionalized for sequence-specific studies, including polyamine-mimetic architectures and side-chain constrained analogs relevant to peptide science.
2. Side-Chain Functionalization
Fmoc-Orn(Dde)-OH serves as a chiral building block for amino acid modification workflows that target the ornithine ε-amino group with orthogonal protection logic. The Dde group can be removed under conditions compatible with Fmoc-based assembly logic, revealing a primary amine suitable for forming ureas, amides, sulfonamides, or carbamates depending on the electrophile used in the subsequent step. The protected carboxylic acid and Fmoc carbamate allow the compound to be introduced into growing peptides or to be handled as a defined intermediate before conjugation chemistry. Downstream derivatives can include labeled polyamines, affinity handles for pull-down assays, or bifunctional linkers that preserve stereochemical integrity of the ornithine α-center.
3. Bioconjugation Chemistry
Fmoc-Orn(Dde)-OH is applied in bioconjugation and chemical biology to generate controlled amine-bearing conjugation sites derived from ornithine side chains. The Dde-protected primary amine provides a latent nucleophile that can be revealed for coupling to activated esters, isothiocyanates, aldehydes, or other electrophiles used to attach biomolecule-compatible tags. The Fmoc group supports incorporation into peptide carriers or linkers, enabling preparation of conjugates with defined attachment topology rather than relying on heterogeneous amine reactivity. The resulting conjugation-ready intermediates support construction of peptide-based probes, multivalent binding constructs, and modular labeling reagents that align with amino acid derivatization strategies.
4. Peptidomimetics And SAR
Fmoc-Orn(Dde)-OH is suitable for peptidomimetic construction and structure-activity relationship studies where ornithine-like polyamine spacing influences molecular recognition. The side-chain amine, once unmasked from the Dde group, can be used to tune hydrogen-bonding patterns, charge density, and potential for salt-bridge formation in analog series. The Fmoc-enabled incorporation into peptide backbones supports systematic variation of side-chain substitution patterns while maintaining a consistent chiral α-amino acid core. The ability to generate a sequence-defined polyamine handle supports SAR workflows that compare analogs bearing different N-substituents, cyclization motifs, or conjugation-ready functional groups.
5. Pharmaceutical Manufacturing Intermediates
Fmoc-Orn(Dde)-OH can be employed in pharmaceutical intermediate preparation for manufacturing routes that rely on protected amino acids compatible with peptide coupling and controlled deprotection steps. The Fmoc carbamate and Dde side-chain protection pattern supports orthogonal processing logic, allowing isolation of defined intermediates that can be carried through purification and subsequent assembly steps without premature side-chain exposure. The carboxylic acid enables conversion to activated derivatives for peptide bond formation, while the latent primary amine supports downstream functional group installation required for drug-like peptide analogs and related fine chemicals. The compound's protected structure aligns with industrially relevant amino acid chemistry where orthogonal protecting groups help manage chemoselectivity during scale-up synthesis and intermediate generation.
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.